Free Trial
NASDAQ:JMAC

Maxpro Capital Acquisition (JMAC) Stock Price, News & Analysis

Maxpro Capital Acquisition logo
$9.75 +0.38 (+4.06%)
(As of 12/20/2024 ET)

About Maxpro Capital Acquisition Stock (NASDAQ:JMAC)

Key Stats

Today's Range
$7.62
$10.50
50-Day Range
$0.09
$11.53
52-Week Range
$7.50
$19.22
Volume
194,297 shs
Average Volume
74,040 shs
Market Capitalization
$130.92 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Maxpro Capital Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in Taipei City, Taiwan.

Receive JMAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Maxpro Capital Acquisition and its competitors with MarketBeat's FREE daily newsletter.

JMAC Stock News Headlines

Wall Street Icon: “You must get on the right side of this thing”
I created one of the first quantitative analysis-based stock picking systems long before "quants" became a thing on Wall Street… leading Forbes to call me "King of the Quants." I'm writing to you today because my system has recently uncovered a market phenomenon I haven't seen in 30 years.
Maxpro Capital Acquisition Corp
See More Headlines

JMAC Stock Analysis - Frequently Asked Questions

Maxpro Capital Acquisition's stock was trading at $0.9650 at the beginning of the year. Since then, JMAC stock has increased by 910.4% and is now trading at $9.75.
View the best growth stocks for 2024 here
.

Shares of JMAC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Maxpro Capital Acquisition investors own include Meta Platforms (META), PhaseBio Pharmaceuticals (PHAS), Dermata Therapeutics (DRMA), Daifuku (DAIUF), CXApp (CXAI), Centogene (CNTG) and China Jo-Jo Drugstores (CJJD).

Company Calendar

Today
12/21/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Holding & other investment offices
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:JMAC
Web
N/A
Fax
N/A
Employees
2,021
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
10,840,000
Market Cap
$130.92 million
Optionable
Not Optionable
Beta
0.01
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

This page (NASDAQ:JMAC) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners